Etifoxine
- Generic Name
- Etifoxine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H17ClN2O
- CAS Number
- 21715-46-8
- Unique Ingredient Identifier
- X24X82MX4X
- Background
Etifoxine is an anxiolytic and anticonvulsant drug developed by Hoechst in the 1960s. It is used in anxiety disorders and to promote peripheral nerve healing. It does not bind to the benzodiazepine receptor though the effects are similar to that of benzodiazepines. It is more effective than lorazepam as an anxiolytic, and has fewer side effects. Etifoxine ha...
- Indication
适用于焦虑症引起的身心障碍、自主神经功能紊乱，尤其是心血管系统方面的表现。
- Associated Conditions
- Anxiety
- Associated Therapies
- -
Validation of the 18 kiloDalton Translocator Protein (TSPO) as a Novel Neuroimmunodulatory Target
- First Posted Date
- 2019-02-21
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 44
- Registration Number
- NCT03850301
- Locations
- 🇬🇧
Imperial College Healthcare NHS Trust, London, England, United Kingdom
Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-05-26
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- Biocodex
- Target Recruit Count
- 31
- Registration Number
- NCT02147548
- Locations
- 🇫🇷
Centre d'Investigation Clinique, CIC 1403 INSERM/CHRU, Lille, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath